Apoptosis

The number of cells in multicellular organism is tightly regulated. Not simply by controlling the rate of cell division, but also by controlling the rate of cell death. If cells are no longer needed, they commit suicide by activating an intracellular death program. This process is therefore called programmed cell death or apoptosis (from a Greek word meaning “falling off,” as leaves from a tree). The intrinsic apoptotic pathway occurs by the release of cytochrome c from mitochondria. The extrinsic apoptotic pathway is caused by the binding of death ligands, such as TNF (tumor necrosis factor), Fas, and TRAIL (TNF-related-apoptosis-inducing ligand), to their corresponding receptors. Although programmed cell death is involved in a number of key biological phenomena, aberrant apoptosis results in diverse human diseases [1]
The amount of apoptosis that occurs in developing and adult animal tissues is surprisingly large. In the developing vertebrate nervous system up to half or more of the nerve cells normally die soon after they are formed. In a healthy adult human, billions of cells die in the bone marrow and intestine every hour. Although this process seems remarkably wasteful -especially as the vast majority are perfectly healthy at the time they kill themselves- programmed cell death plays an important role during embryonic development, as hands and feet, for example, are sculpted by apoptosis: they start out as spadelike structures, and the individual digits separate only as the cells between them die. In other cases, cells die when the structure they form is no longer needed. When a tadpole changes into a frog, the cells in the tail die, and the tail, which is not needed in the frog, disappears. In many other cases, cell death helps regulate cell numbers. In the developing nervous system, for example, cell death adjusts the number of nerve cells to match the number of target cells that require innervation. In all these cases, the cells die by apoptosis as well[2].


[2] D.R. Williams et al. An apoptosis-inducing small molecule that binds to heat shock protein 70. Angew. Chem. Int. Ed. Engl. 2008, 47, 7466-7469.
[1] B. Alberts, A. Johnson, J. Lewis et al. Molecular Biology of the Cell. 4th edition. New York. Garland Science, 2002. 

Items 1 to 30 of 60 total

per page
Page:
  1. 1
  2. 2
Axon ID Name Description From price
3039 ACY-241 Selective and orally available HDAC6 inhibitor €120.00
2269 AK 1 Potent inhibitor of SIRT with good selectivity for SIRT2 over SIRT1 and SIRT3 €90.00
2270 AK 7 Potent, brain-permeable and selective inhibitor of SIRT2 €90.00
2394 AR-42 HDAC inhibitor €125.00
5052 Axon Ligands™ Epigenetic compound library Axon Ligands™ Epigenetic compound library Inquire
2635 BAY-598 Selective inhibitor of SMYD2 €110.00
2735 BCI-121 Inhibitor of SMYD3 €90.00
3115 Belinostat HDAC inhibitor €70.00
3397 BG45 HDAC inhibitor (1, 2, 3 Selective) €80.00
1692 BIX 01294 trihydrochloride HMTase inhibitor (G9a and G9a-like protein) €80.00
3399 BML-210 HDAC inhibitor €80.00
2471 BRD 73954 Dual HDAC 6/8 inhibitor with excellent selectivity over the other HDACs €85.00
2803 Cambinol Inhibitor of SIRT1 and SIRT2 €95.00
2250 CHR 6494 trifluoroacetate Specific, first-in-class inhibitor of histone kinase Haspin €120.00
2014 CI 994 HDAC inhibitor that causes histone hyperacetylation in living cells €70.00
2812 CM-272 First-in-class potent, selective and reversible inhibitor of G9a/DNMT €130.00
2594 CPI 0610 Selective and metabolically stable inhibitor of BET bromodomains Inquire
3038 CXD101 HDAC inhibitor (1, 2, 3 Selective) €125.00
2227 EPZ 6438 Inhibitor of Histone Lysine Methyltransferase EZH2 €80.00
4137 EPZ005687 hydrochloride EZH2 HMTase inhibitor Inquire
2140 GSK 126 Inhibitor of Histone Lysine Methyltransferase EZH2 €75.00
1645 HDAC6 inhibitor ISOX HDAC6 Inhibitor €110.00
2529 JNJ 26481585 dihydrochloride Potent, orally available second-generation pan-HDAC inhibitor €125.00
1548 LBH 589 HDAC1 Inhibitor €90.00
2430 LW 479 HDAC inhibitor with cytotoxicity in a panel of breast cancer cell lines. €135.00
1707 MC 1568 HDAC inhibitor (class IIA selective) €85.00
2505 Mocetinostat Class I selective HDAC inhibitor with broad spectrum antitumor activity €80.00
1803 MS 275 Inhibitor of HDAC (1 and 3 Selective) €60.00
3469 MS1943 trifluoroacetate First-in-class EZH2 selective degrader; PROTAC €200.00
2359 Nexturastat A HDAC6 inhibitor with good selectivity over HDAC1 and HDAC8 €90.00

Items 1 to 30 of 60 total

per page
Page:
  1. 1
  2. 2
Please wait...